Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: An analysis of 256,381 in vitro fertilization cycles

Fertility and Sterility

Volumn 101, Issue 4, 2014, Pages 967-973

  Steward, Ryan G ^a   Lan, Lan ^b   Shah, Anish A ^a   Yeh, Jason S ^a   Price, Thomas M ^a   Goldfarb, James M ^c   Muasher, Suheil J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University Hospitals Fertility Center   (United States)

Author keywords

live birth; Oocyte number; ovarian hyperstimulation syndrome; pregnancy

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; FEMALE GENITAL TRACT PARAMETERS; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; OOCYTE; OOCYTE NUMBER; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PREDICTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REGISTER; RETROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

LIVE BIRTH; OOCYTE NUMBER; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY;

ADULT; CELL COUNT; COHORT STUDIES; FEMALE; FERTILIZATION IN VITRO; HUMANS; INCIDENCE; LIVE BIRTH; MIDDLE AGED; OOCYTE RETRIEVAL; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES;

EID: 84897458437     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2013.12.026     Document Type: Article

References (47)

1. What is assisted reproductive technology? Most recent ART data. Atlanta, Georgia: Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion 2013. Available at: www.cdc.gov/ART/index.htm. Accessed July 17, 2013.
2. A. Delvigne, J. Vandromme, P. Barlow, B. Lejeune, and F. Leroy Are there predictive criteria of complicated ovarian hyperstimulation in IVF? Hum Reprod 6 1991 959 962
3. R.H. Asch, H.P. Li, J.P. Balmaceda, L.N. Weckstein, and S.C. Stone Severe ovarian hyperstimulation syndrome in assisted reproductive technology: definition of high risk groups Hum Reprod 6 1991 1395 1399
4. A. Golan, R. Ron-El, A. Herman, Y. Soffer, Z. Weinraub, and E. Caspi Ovarian hyperstimulation syndrome: an update review Obstet Gynecol Surv 44 1989 430 440
5. A. Enskog, M. Henriksson, M. Unander, L. Nilsson, and M. Brännström Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization Fertil Steril 71 1999 808 814
6. R.S. Morris, R.J. Paulson, M.V. Sauer, and R.A. Lobo Predictive value of serum oestradiol concentrations and oocyte number in severe ovarian hyperstimulation syndrome Hum Reprod 10 1995 811 814
7. E.G. Papanikolaou, C. Pozzobon, E.M. Kolibianakis, M. Camus, H. Tournaye, and H.M. Fatemi et al. Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles Fertil Steril 85 2006 112 120
8. E. Mocanu, M.L. Redmond, B. Hennelly, C. Collins, and R. Harrison Odds of ovarian hyperstimulation syndrome (OHSS) - time for reassessment Hum Fertil (Camb) 10 2007 175 181
9. E. Rabau, A. David, D.M. Serr, S. Mashiach, and B. Lunenfeld Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment Am J Obstet Gynecol 98 1967 92 98
10. J.G. Schenker, and D. Weinstein Ovarian hyperstimulation syndrome: a current survey Fertil Steril 30 1967 255 268
11. A. Tollan, N. Holst, F. Forsdahl, H.O. Fadnes, P. Oian, and J.M. Maltau Transcapillary fluid dynamics during ovarian stimulation for in vitro fertilization Am J Obstet Gynecol 162 1990 554 558
12. M.P. Goldsman, A. Pedram, C.E. Dominguez, I. Ciuffardi, E. Levin, and R.H. Asch Increased capillary permeability induced by human follicular fluid: a hypothesis for an ovarian origin of the hyperstimulation syndrome Fertil Steril 63 1995 268 272
13. C.A. Lyons, C.A. Wheeler, G.N. Frishman, R.J. Hackett, D.B. Seifer, and R.V. Haning Jr. Early and late presentation of the ovarian hyperstimulation syndrome: two distinct entities with different risk factors Hum Reprod 9 1994 792 799
14. D. Navot, A. Relou, A. Birkenfeld, R. Rabinowitz, A. Brzezinski, and E.J. Margalioth Risk factors and prognostic variables in the ovarian hyperstimulation syndrome Am J Obstet Gynecol 159 1988 210 215
15. A. Delvigne, M. Dubois, B. Battheu, S. Bassil, C. Meuleman, and P. de Sutter et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. II. Multiple discriminant analysis for risk prediction Hum Reprod 8 1993 1361 1366
16. M.J. MacDougall, S.L. Tan, and H.S. Jacobs In-vitro fertilization and the ovarian hyperstimulation syndrome Hum Reprod 7 1992 597 600
17. R.G. Forman, R. Frydman, D. Egan, C. Ross, and D.H. Barlow Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention Fertil Steril 53 1990 502 509
18. C.D. Chen, M.Y. Wu, K.H. Chao, S.U. Chen, H.N. Ho, and Y.S. Yang Serum estradiol level and oocyte number in predicting severe ovarian hyperstimulation syndrome J Formos Med Assoc 96 1997 829 834
19. M. Reljic, V. Vlaisavljević, V. Gavrić, and B. Kovacic Number of oocytes retrieved and resulting pregnancy. Risk factors for ovarian hyperstimulation syndrome J Reprod Med 44 1999 713 718
20. J. Blankstein, J. Shalev, T. Saadon, E.E. Kukia, J. Rabinovici, and C. Pariente et al. Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles Fertil Steril 47 1987 597 602
21. B. McAvey, A. Zapantis, S.K. Jindal, H.J. Lieman, and A.J. Polotsky How many eggs are needed to produce an assisted reproductive technology baby: is more always better? Fertil Steril 96 2011 332 335
22. P. Patrizio, and D. Sakkas From oocyte to baby: a clinical evaluation of the biological efficiency of in vitro fertilization Fertil Steril 91 2009 1061 1066
23. G.B. Inge, P.R. Brinsden, and K.T. Elder Oocyte number per live birth in IVF: were Steptoe and Edwards less wasteful? Hum Reprod 20 2005 588 592
24. S.K. Sunkara, V. Rittenberg, N. Raine-Fenning, S. Bhattacharya, J. Zamora, and A. Coomarasamy Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles Hum Reprod 26 2011 1768 1774
25. A. Golan, and A. Weissman Symposium: update on prediction and management of OHSS. A modern classification of OHSS Reprod Biomed Online 19 2009 28 32
26. K.Y. Liang, and S.L. Zeger Longitudinal data analysis using generalized linear models Biometrics 73 1986 13 22
27. A.E. Hubbard, J. Ahern, N.L. Fleischer, M. van der Laan, S.A. Lippman, and N. Jewell et al. To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighborhood risk factors and health Epidemiology 21 2010 467 474
28. Confidential enquiry into maternal and child health. Saving mothers' lives: reviewing maternal deaths to make motherhood safer 2003-2005. The seventh report of the confidential enquiries into maternal death in the UK. Obstetric Medicine: The Medicine of Pregnancy 2008;1:54.
29. D.D. Braat, J.M. Schutte, R.E. Bernardus, T.M. Mooij, and van Leeuwen Fe Maternal death related to IVF in the Netherlands 1984-2008 Hum Reprod 25 2010 1782 1786
30. G.I. Meniru, and I.L. Craft Utilization of retrieved oocytes as an index of the efficiency of superovulation strategies for in-vitro fertilization treatment Hum Reprod 12 1997 2129 2132
31. H. Hamoda, S. Sunkara, Y. Khalaf, P. Braude, and T. El-Toukhy Outcome of fresh IVF/ICSI cycles in relation to the number of oocytes collected: a review of 4,701 treatment cycles Hum Reprod 25 2010 147
32. B.C. Fauser, D. de Jong, F. Olivennes, H. Wramsby, C. Tay, and J. Itskovitz-Eldor et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization J Clin Endocrinol Metab 87 2002 709 715
33. P. Humaidan, H.E. Bredkjaer, L. Bungum, M. Bungum, M.L. Grondahl, and L. Westergaard et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study Hum Reprod 20 2005 1213 1220
34. E.M. Kolibianakis, A. Schultze-Mosgau, A. Schroer, A. van Steirteghem, P. Devroey, and K. Diedrich et al. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists Hum Reprod 20 2005 2887 2892
35. K. Oktay, I. Turkcuoglu, and K.A. Rodriguez-Wallberg GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation Reprod Biomed Online 20 2010 783 788
36. G. Griesinger, K. Diedrich, P. Devroey, and E.M. Kolibianakis GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis Hum Reprod Update 12 2006 159 168
37. P. Humaidan, S. Kol, and E.G. Papanikolaou GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum Reprod 17 2011 510 524
38. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, C. Hudson, and S. Thomas Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders Fertil Steril 96 2011 516 518
39. B.S. Shapiro, S.T. Daneshmand, F.C. Garner, M. Aguirre, C. Hudson, and S. Thomas Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders Fertil Steril 96 2011 344 348
40. B.S. Shapiro, S.T. Daneshmand, H. Restrepo, F.C. Garner, M. Aguirre, and C. Hudson Matched-cohort comparison of single-embryo transfers in fresh and frozen-thawed embryo transfer cycles Fertil Steril 99 2013 389
41. R. Forman, N. Fries, J. Testart, J. Belaisch-Allart, A. Hazout, and R. Frydman Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation Fertil Steril 49 1988 118 122
42. C. Simon, F. Coro, D. Valbuena, J. Remohi, and A. Pellicer Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients Hum Reprod 10 1995 2432 2437
43. C. Simon, J.I. Garcia Velasco, D. Valbuena, J.A. Peinado, C. Moreno, and J. Remohí et al. Increasing uterine receptivity by decreasing oestradiol levels during the preimplantation period in high responders with the use of a follicle stimulating hormone step-down regimen Fertil Steril 70 1998 234 239
44. B.S. Joo, S.H. Park, B.M. An, K.S. Kim, S.E. Moon, and H.S. Moon Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner Fertil Steril 93 2010 442 446
45. E.H. Ng What is the threshold value for serum estradiol levels associated with adverse IVF outcomes? Fertil Steril 73 2000 1071 1072
46. C.-H. Wu, T.-C. Kuo, H.-H. Wu, G.-P. Yeh, and H.-D. Tsai High serum estradiol levels are not detrimental to in vitro fertilization outcome Taiwan J Obstet Gynecol 46 2007 54 59
47. M. Baumgarten, L. Polanski, B. Campbell, and N. Raine-Fenning Do dopamine agonists prevent or reduce the severity of ovarian hyperstimulation syndrome in women undergoing assisted reproduction? A systematic review and meta-analysis Human Fertil (Camb) 16 2013 168 174